Sattva Sukun Lifecare Intrinsic Value
Sattva Sukun Lifecare (SATTVASUKU) median intrinsic value is ₹2.25 from 8 valuation models (range ₹2–₹2), vs current price ₹0.75 — +200.0% upside (Trading Below Calculated Value), margin of safety 66.7%. For current market price and key ratios, visit Sattva Sukun Lifecare share price today.
SATTVASUKU Valuation Methods Summary — DCF, Graham Number & P/E
Sattva Sukun Lifecare intrinsic value across 8 models vs current price ₹0.75 — upside/downside and value range per method. Browse Sattva Sukun Lifecare financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.25 | ₹1.80 - ₹2.70 | +200.0% | EPS: ₹0.36, Sector P/E: 12x |
| Book Value Method | asset | ₹1.88 | ₹1.69 - ₹2.07 | +150.7% | Book Value/Share: ₹12.63, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.50 | ₹1.35 - ₹1.65 | +100.0% | Revenue/Share: ₹35.79, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1.50 | ₹1.35 - ₹1.65 | +100.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹2.25 | ₹2.02 - ₹2.48 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2.25 | ₹2.02 - ₹2.48 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1.50 | ₹1.35 - ₹1.65 | +100.0% | ROE: 16.7%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹2.25 | ₹2.02 - ₹2.48 | +200.0% | EPS: ₹0.36, BVPS: ₹12.63 |
SATTVASUKU Intrinsic Value vs Market Price — All Valuation Models
Sattva Sukun Lifecare fair value range ₹2–₹2 vs current market price ₹0.75 across 8 valuation models. Also explore Sattva Sukun Lifecare share price performance to track price trends across different timeframes.
SATTVASUKU Intrinsic Value Analysis — Undervalued or Overvalued?
Sattva Sukun Lifecare median intrinsic value ₹2.25, current price ₹0.75 — Trading Below Calculated Value by 200.0%, margin of safety 66.7%.
What is the intrinsic value of SATTVASUKU?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sattva Sukun Lifecare (SATTVASUKU) is ₹2.25 (median value). With the current market price of ₹0.75, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹1.50 to ₹2.25, indicating ₹1.50 - ₹2.25.
Is SATTVASUKU undervalued or overvalued?
Based on our multi-method analysis, Sattva Sukun Lifecare (SATTVASUKU) appears to be trading below calculated value by approximately 200.0%.
SATTVASUKU Financial Health — Key Ratios vs Industry Benchmarks
Sattva Sukun Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 16.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.52x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SATTVASUKU Cash Flow Quality — Operating & Free Cash Flow
Sattva Sukun Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |